Baseline MELD score predicts hepatic decompensation during antiviral therapy in patients with chronic hepatitis C and advanced cirrhosis
- Language
-
Englisch
- Identifier
-
1081036834
Contributor
Dultz, Georg
Seelhof, Martin
Herrmann, Eva
Welker, Martin-Walter
Friedrich-Rust, Mireen
Teuber, Gerlinde
Kronenberger, Bernd
Wagner, Michael von
Vermehren, Johannes
Sarrazin, Christoph
Zeuzem, Stefan
Hofmann, Wolf Peter
Seelhof, Martin
Herrmann, Eva
Welker, Martin-Walter
Friedrich-Rust, Mireen
Teuber, Gerlinde
Kronenberger, Bernd
Wagner, Michael von
Vermehren, Johannes
Sarrazin, Christoph
Zeuzem, Stefan
Hofmann, Wolf Peter
- URN
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
26.01.2023, 1:53 PM CET
Associated
- Dultz, Georg
- Seelhof, Martin
- Herrmann, Eva
- Welker, Martin-Walter
- Friedrich-Rust, Mireen
- Teuber, Gerlinde
- Kronenberger, Bernd
- Wagner, Michael von
- Vermehren, Johannes
- Sarrazin, Christoph
- Zeuzem, Stefan
- Hofmann, Wolf Peter
Other Objects (12)
Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity
Non-invasive assessment of fibrosis regression and portal hypertension in patients with advanced chronic hepatitis C virus (HCV)-associated liver disease and sustained virologic response (SVR): 3 years follow-up of a prospective longitudinal study
Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response
Concise review : interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection
Serum sphingolipid variations associate with hepatic decompensation and survival in patients with cirrhosis
Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C
AFP ratio predicts HCC recurrence after liver transplantation
Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers
Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study
Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura
Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis
Serum microRNA-122 predicts survival in patients with liver cirrhosis
Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity
Non-invasive assessment of fibrosis regression and portal hypertension in patients with advanced chronic hepatitis C virus (HCV)-associated liver disease and sustained virologic response (SVR): 3 years follow-up of a prospective longitudinal study
Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response
Concise review : interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection
Serum sphingolipid variations associate with hepatic decompensation and survival in patients with cirrhosis
Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C
AFP ratio predicts HCC recurrence after liver transplantation
Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers
Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study
Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura
Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis
Serum microRNA-122 predicts survival in patients with liver cirrhosis
Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity
Non-invasive assessment of fibrosis regression and portal hypertension in patients with advanced chronic hepatitis C virus (HCV)-associated liver disease and sustained virologic response (SVR): 3 years follow-up of a prospective longitudinal study
Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response
Concise review : interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection
Serum sphingolipid variations associate with hepatic decompensation and survival in patients with cirrhosis
Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C
AFP ratio predicts HCC recurrence after liver transplantation
Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers
Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study
Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura
Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis